True prevalence of twin HDV-HBV infection in Pakistan: A molecular approach

Virology Journal

Volumn 8, Issue , 2011, Pages

  Khan, Asad U ^a   Waqar, Muhammad ^a   Akram, Madiha ^b   Zaib, Mehnaz ^b   Wasim, Muhammad ^c   Ahmad, Shahzad ^a   Niaz, Zeeshan ^a   Ali, Sajid ^a   Ali, Haider ^a   Idrees, Muhammad ^d   Bajwa, Mohammad A ^e  

^a HAZARA UNIVERSITY   (Pakistan)

^b Genome Center for Molecular Diagnostics and Research   (Pakistan)

^c KHYBER MEDICAL UNIVERSITY   (Pakistan)

^d UNIVERSITY OF THE PUNJAB   (Pakistan)

^e Sheikh Zayed Medical Complex ^*  (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; PAKISTAN; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADOLESCENT; AGED; CHILD; DELTA AGENT HEPATITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED; PHYLOGEOGRAPHY; VIROLOGY;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; SATELLITE VIRUSES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COINFECTION; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; PAKISTAN; PHYLOGEOGRAPHY; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; YOUNG ADULT;

EID: 80052257385     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-420     Document Type: Article

References (20)

1. World Health Organization Hepatitis Delta. http://www.searo.who.int/EN/ Section10/Section1027-9489.htm [WHO/CDS/CSR/NCS/2001.1]
2. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, J Infect Dis 1980 141 590 602 10.1093/infdis/141.5.590 6989929 (Pubitemid 10109828)
3. Eight clade for hepatitis delta virus. Gal FL, Gault E, Rapault MP, Serpaggi J, Trinchet JC, Gordien E, Emerging Infect Dis 2006 12 1447 1450 17073101 (Pubitemid 44455228)
4. Hepatitis delta virus. Gerin JL, Cassey JL, Purcell RH, Viral Hepatitis Philadelphia: Lippincott Williams and Wilkins, Hollinger FB, Purcell RH,Gerin JL, 2002 169 182
5. Molecular phylogenetic analyses indicate a wide and ancient radiation African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, J Virol 2004 78 2537 2544 10.1128/JVI.78.5.2537-2544.2004 14963156 (Pubitemid 38228948)
6. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. Gal FL, Gordien E, Affolabi D, Hanslik T, Alloui C, Dény P, J Clin Micro 2005 43 2363 2369 10.1128/JCM.43.5.2363-2369.2005 (Pubitemid 40656252)
7. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Polson AG, Bass BL, Casey JL, Nature 1996 380 454 456 10.1038/380454a0 8602246
8. HIV and hepatitis delta virus: evolution takes different paths to relieve blocks in transcriptional elongation. Yamaguchi Y, Deléhouzée S, Handa H, Microb Infect 2002 4 1169 1175 10.1016/S1286-4579(02)01641-6 (Pubitemid 35279524)
9. Delta hepatitis: an update. Farci P, J Hepatol 2003 39 Suppl 1 212 S219 14708706
10. Hepatitis D. Husa P, Linhartová A, Nemecek V, Husová L, Acta Virol 2005 49 219 225 16402678 (Pubitemid 47434343)
11. Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study. Liaw YF, Chiu KW, Chu CM, Sheen IS, Huang MJ, J Infect Dis 1990 162 1170 1172 10.1093/infdis/162.5.1170 2121838
12. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. Novick DM, J Infect Dis 1988 158 795 803 10.1093/infdis/158.4.795 3171227
13. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. Stroffolini T, J Hepatol 1994 21 1123 1126 10.1016/S0168-8278(05)80629-4 7699238
14. Molecular Epidemiology of Hepatitis D Virus Infection among Injecting Drug Users with and without Human Immunodeficiency Virus Infection in Taiwan. Chang Sy, Yang CL, Ko WS, Liu WC, Lin CY, Wu CS, Su YC, Chang SF, Chen MY, Sheng WH, Hung CC, Chang SC, J Clin Microbiol 2011 49 1083 1089 10.1128/JCM.01154-10 21191061
15. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. Mumtaz K, Hamid SS, Adil S, J Gastroenterol Hepatol 2005 20 1503 7 10.1111/j.1440-1746.2005.03857.x 16174065 (Pubitemid 43961102)
16. Frequency and comparative analysis of hepatitis D in patients seeking treatment for hepatitis B. Zuberi BF, Quraishy MS, Afsar S, J Coll Physicians Surg Pak 2006 16 581 4 16945230 (Pubitemid 44566685)
17. Molecular cloning and sequencing of a human delta virus RNA. Makino S, Change MF, Sheikh CK, Kamahora T, Vannier DM, Govindarejin S, Nature 1987 329 343 346 10.1038/329343a0 3627276 (Pubitemid 17134359)
18. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. Novick DM, J Infect Dis 1988 158 795 803 10.1093/infdis/158.4.795 3171227
19. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. Stroffolini T, J Hepatol 1994 21 1123 1126 10.1016/S0168-8278(05)80629-4 7699238
20. High Prevalence and Predominance of Hepatitis Delta Virus Genotype 1 Infection in Cameroon. Foupouapouognigni Y, Noah DN, Sartre MT, Njouom R, J Clin Microbiol 2011 49 1162 1164 10.1128/JCM.01822-10 21209162